“…The evolution of PEDV has been complex and rapid, with potential recombination events occurring between the G1a and G2 lineages and leading to new lineages such as S-INDEL (G1b) and the newly identified G2c [ 10 , 27 , 28 , 29 ]. Changes in the S gene through mutation and recombination can alter the pathogenicity of the virus and its ability to infect different tissues or species [ 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. The S protein is also vital for infection, as it induces the production of neutralizing antibodies and is a key target for vaccine development, both for live attenuated and subunit vaccines [ 22 ].…”